Brief: VBI Announces Agreement To Sell Manufacturing Capabilities, Enter Into License Agreement With Brii Biosciences

VBI Vaccines

14/02/2024 12:15

Feb 14 (Reuters) - VBI Vaccines Inc  VBIV.O :
    * VBI ANNOUNCES AGREEMENT TO SELL MANUFACTURING
CAPABILITIES,
CERTAIN RELATED ASSETS, AND ENTER INTO NEW LICENSE AGREEMENT
WITH BRII BIOSCIENCES
    * VBI VACCINES INC - VBI TO RECEIVE UP TO $33 MILLION IN
CONSIDERATION
    * VBI VACCINES INC - PROCEEDS FROM AGREEMENTS WILL BE USED
FOR
REDUCTION OF DEBT UNDER COMPANY'S CURRENT FACILITY WITH K2
HEALTHVENTURES
    * VBI VACCINES INC - RECEIVED $2.5 MILLION OF CONSIDERATION
UPON
SIGNING OF DEFINITIVE DOCUMENTS
    * VBI VACCINES INC -  BRII BIO EXPECTED TO ACQUIRE
INTELLECTUAL
PROPERTY FOR VBI-2601
    * VBI VACCINES INC - BRII BIO EXPECTED TO ACQUIRE
MANUFACTURING
CAPABILITIES AND CERTAIN RELATED ASSETS AT VBI'S REHOVOT, ISRAEL
MANUFACTURING FACILITY
    * VBI VACCINES INC - BRII BIO EXPECTED TO ENTER INTO AN
EXCLUSIVE
LICENSE TO DEVELOP AND COMMERCIALIZE VBI-1901

Source text for Eikon:  ID:nBw6whTdna 
Further company coverage:  VBIV.O 

 ((Reuters.Briefs@thomsonreuters.com;))